Macrophages at the interface of the co-evolving cancer ecosystem

[1]  P. Siegel,et al.  Single-cell spatial immune landscapes of primary and metastatic brain tumours , 2023, Nature.

[2]  Xiaoji G. Xu,et al.  Inducing trained immunity in pro-metastatic macrophages to control tumor metastasis , 2023, Nature Immunology.

[3]  K. Lindblad,et al.  Immunoediting instructs tumor metabolic reprogramming to support immune evasion. , 2023, Cell metabolism.

[4]  Xiuyue Zhang,et al.  Tumor cells-derived conditioned medium induced pro-tumoral phenotypes in macrophages through calcium-nuclear factor κB interaction , 2022, BMC Cancer.

[5]  K. Flaherty,et al.  Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth. , 2022, Nature metabolism.

[6]  U. Flögel,et al.  Multispectral fluorine-19 MRI enables longitudinal and noninvasive monitoring of tumor-associated macrophages , 2022, Science Translational Medicine.

[7]  Paolo P. Provenzano,et al.  Targeting TNF-α–producing macrophages activates antitumor immunity in pancreatic cancer via IL-33 signaling , 2022, JCI insight.

[8]  J. Hsieh,et al.  Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer. , 2022, Immunity.

[9]  Yuqin Liu,et al.  Crosstalk between tumor-associated macrophages and tumor cells promotes chemoresistance via CXCL5/PI3K/AKT/mTOR pathway in gastric cancer , 2022, Cancer Cell International.

[10]  Lin Zhao,et al.  The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies , 2022, Molecular Cancer.

[11]  C. Jakubzick,et al.  Biology of lung macrophages in health and disease. , 2022, Immunity.

[12]  Cheorl-Ho Kim,et al.  Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells , 2022, International journal of molecular sciences.

[13]  Yihai Cao,et al.  Brown-fat-mediated tumour suppression by cold-altered global metabolism , 2022, Nature.

[14]  V. Boussiotis,et al.  The complex role of tumor-infiltrating macrophages , 2022, Nature Immunology.

[15]  Ping-Chih Ho,et al.  Lipid-loaded macrophages as new therapeutic target in cancer , 2022, Journal for ImmunoTherapy of Cancer.

[16]  L. Akkari,et al.  Therapy-induced shaping of the glioblastoma microenvironment: Macrophages at play. , 2022, Seminars in cancer biology.

[17]  P. Matzinger,et al.  Neoantigen Presentation and IFNγ Signaling on the Same Tumor-associated Macrophage are Necessary for CD4 T Cell–mediated Antitumor Activity in Mice , 2022, Cancer research communications.

[18]  M. Pittet,et al.  Clinical relevance of tumour-associated macrophages , 2022, Nature Reviews Clinical Oncology.

[19]  Lianghai Wang,et al.  Integrated Analysis Highlights the Immunosuppressive Role of TREM2+ Macrophages in Hepatocellular Carcinoma , 2022, Frontiers in Immunology.

[20]  I. Amit,et al.  Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting , 2022, Nature Cancer.

[21]  Yu Lin,et al.  Primary tumor associated macrophages activate programs of invasion and dormancy in disseminating tumor cells , 2022, Nature Communications.

[22]  L. Delort,et al.  The Impact of Obesity, Adipose Tissue, and Tumor Microenvironment on Macrophage Polarization and Metastasis , 2022, Biology.

[23]  D. Hanahan.  Hallmarks of Cancer: New Dimensions. , 2022, Cancer discovery.

[24]  A. Khattri,et al.  Pan-Cancer Analysis Shows Enrichment of Macrophages, Overexpression of Checkpoint Molecules, Inhibitory Cytokines, and Immune Exhaustion Signatures in EMT-High Tumors , 2022, Frontiers in Oncology.

[25]  M. Klichinsky,et al.  Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors , 2021, Frontiers in Immunology.

[26]  Jian Zhang,et al.  Single-Cell RNA Sequencing Reveals the Heterogeneity of Tumor-Associated Macrophage in Non-Small Cell Lung Cancer and Differences Between Sexes , 2021, Frontiers in Immunology.

[27]  A. Trumpp,et al.  TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer , 2021, Nature Cancer.

[28]  Santiago J. Carmona,et al.  Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation. , 2021, Cancer cell.

[29]  Niranjan Venkateswaran,et al.  Tryptophan and its metabolites in normal physiology and cancer etiology , 2021, The FEBS journal.

[30]  P. Allavena,et al.  Macrophages and cancer stem cells: a malevolent alliance , 2021, Molecular Medicine.

[31]  Sang-Mi Cho,et al.  CXCL5 secreted from macrophages during cold exposure mediates white adipose tissue browning , 2021, Journal of lipid research.

[32]  A. Devitt,et al.  Macrophages: The Good, the Bad, and the Gluttony , 2021, Frontiers in Immunology.

[33]  C. Anderson,et al.  Somatic mutations provide important and unique insights into the biology of complex diseases. , 2021, Trends in genetics : TIG.

[34]  A. Broeks,et al.  An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer , 2021, Nature Medicine.

[35]  Qi Zhang,et al.  Glucose Metabolism: The Metabolic Signature of Tumor Associated Macrophage , 2021, Frontiers in Immunology.

[36]  S. Pierdomenico,et al.  Epithelial-Mesenchymal Transition (EMT): The Type-2 EMT in Wound Healing, Tissue Regeneration and Organ Fibrosis , 2021, Cells.

[37]  C. Rudin,et al.  Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity. , 2021, Cancer cell.

[38]  S. Heiland,et al.  Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas , 2021, Nature Cancer.

[39]  E. Dees,et al.  A phase 1, first in human study of adenovirally transduced autologous macrophages engineered to contain an anti-HER2 chimeric antigen receptor (CAR) in subjects with HER2 overexpressing solid tumors. , 2021 .

[40]  I. Gögenur,et al.  Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy , 2021, Frontiers in Oncology.

[41]  A. Iavarone,et al.  Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker , 2021, Genome Medicine.

[42]  T. Waldmann,et al.  Immunometabolism at the Nexus of Cancer Therapeutic Efficacy and Resistance , 2021, Frontiers in Immunology.

[43]  S. Nobs,et al.  Tissue-resident macrophages: guardians of organ homeostasis. , 2021, Trends in immunology.

[44]  R. Xiang,et al.  Cancer-derived exosomal miR-138-5p modulates polarization of tumor-associated macrophages through inhibition of KDM6B , 2021, Theranostics.

[45]  A. Dannenberg,et al.  Neutrophil oxidative stress mediates obesity-associated vascular dysfunction and metastatic transmigration , 2021, Nature Cancer.

[46]  W. Guan,et al.  Tumor-Associated Macrophage Promotes the Survival of Cancer Cells upon Docetaxel Chemotherapy via the CSF1/CSF1R–CXCL12/CXCR4 Axis in Castration-Resistant Prostate Cancer , 2021, Genes.

[47]  Y. Saeys,et al.  Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization , 2021, Nature Neuroscience.

[48]  R. Gillies,et al.  Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer , 2021, Cancer Research.

[49]  E. Jonasch,et al.  High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types. , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

[50]  K. Rock,et al.  Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation , 2021, Frontiers in Immunology.

[51]  M. Kornmann,et al.  Involvement of IL-4, IL-13 and Their Receptors in Pancreatic Cancer , 2021, International journal of molecular sciences.

[52]  M. Kesting,et al.  Zoledronate Causes a Systemic Shift of Macrophage Polarization towards M1 In Vivo , 2021, International journal of molecular sciences.

[53]  I. Baranowska-Bosiacka,et al.  The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature , 2021, International journal of molecular sciences.

[54]  A. Chinnaiyan,et al.  Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination , 2021, Nature Medicine.

[55]  M. V. Heiden,et al.  Cell Programmed Nutrient Partitioning in the Tumor Microenvironment , 2020, bioRxiv.

[56]  P. Walker,et al.  Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review , 2020, Journal for ImmunoTherapy of Cancer.

[57]  Jefte M. Drijvers,et al.  Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity , 2020, Cell.

[58]  Aaron J. Johnson,et al.  Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediators. , 2020, Brain : a journal of neurology.

[59]  Chuan-Yuan Li,et al.  PCSK9 inhibition potentiates cancer immune checkpoint therapy , 2020, Nature.

[60]  N. Cross,et al.  The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment , 2020, Frontiers in Immunology.

[61]  W. Han,et al.  Breast cancer cell debris diminishes therapeutic efficacy through heme oxygenase-1-mediated inactivation of M1-like tumor-associated macrophages , 2020, Neoplasia.

[62]  E. Holland,et al.  Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses , 2020, Journal for ImmunoTherapy of Cancer.

[63]  S. Fendt,et al.  Nutrient metabolism and cancer in the in vivo context: a metabolic game of give and take , 2020, EMBO reports.

[64]  A. Bergthaler,et al.  Systemic Immunometabolism: Challenges and Opportunities , 2020, Immunity.

[65]  Min Kyoon Kim,et al.  Effects of Steady Low-Intensity Exercise on High-Fat Diet Stimulated Breast Cancer Progression Via the Alteration of Macrophage Polarization , 2020, Integrative cancer therapies.

[66]  D. Landau,et al.  Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics , 2020, Nature Reviews Genetics.

[67]  Maxim N. Artyomov,et al.  TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy , 2020, Cell.

[68]  Joel s. Brown,et al.  Integrating evolutionary dynamics into cancer therapy , 2020, Nature Reviews Clinical Oncology.

[69]  A. Kros,et al.  Light-triggered switching of liposome surface charge directs delivery of membrane impermeable payloads in vivo , 2020, Nature Communications.

[70]  J. Westerga,et al.  Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance , 2020, Science Translational Medicine.

[71]  D. Aldinucci,et al.  The CCL5/CCR5 Axis in Cancer Progression , 2020, Cancers.

[72]  J. Kzhyshkowska,et al.  Transcriptional, Epigenetic and Metabolic Programming of Tumor-Associated Macrophages , 2020, Cancers.

[73]  S. Mitragotri,et al.  Cellular backpacks for macrophage immunotherapy , 2020, Science Advances.

[74]  G. Hajishengallis,et al.  Phagocytosis of Apoptotic Cells in Resolution of Inflammation , 2020, Frontiers in Immunology.

[75]  Martha E. Zeeman,et al.  Human chimeric antigen receptor macrophages for cancer immunotherapy , 2020, Nature Biotechnology.

[76]  R. Xavier,et al.  Defining trained immunity and its role in health and disease , 2020, Nature Reviews Immunology.

[77]  T. Inaba,et al.  Kdm6a Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with p53 Dysfunction , 2020, Clinical Cancer Research.

[78]  Z. Modrušan,et al.  Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP. , 2020, Immunity.

[79]  B. Perillo,et al.  ROS in cancer therapy: the bright side of the moon , 2020, Experimental & Molecular Medicine.

[80]  J. Hecht,et al.  A phase Ib/II study of the anti-CD47 antibody magrolimab with cetuximab in solid tumor and colorectal cancer patients. , 2020 .

[81]  Y. Doki,et al.  Tumor‐infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancer , 2020, Cancer science.

[82]  Jae Min Lim,et al.  Breast cancer cell-derived soluble CD44 promotes tumor progression by triggering macrophage IL-1β production. , 2020, Cancer research.

[83]  Alimuddin Zumla,et al.  Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future Opportunities , 2020, Frontiers in Microbiology.

[84]  Colin A. Flaveny,et al.  LXR-inverse agonism stimulates immune-mediated tumor destruction by enhancing CD8 T-cell activity in triple negative breast cancer , 2019, Scientific Reports.

[85]  J. Powell,et al.  Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion , 2019, Science.

[86]  Yuquan Wei,et al.  Epigenetic regulation of macrophages: from homeostasis maintenance to host defense , 2019, Cellular & Molecular Immunology.

[87]  F. D. de Sauvage,et al.  The great escape: tumour cell plasticity in resistance to targeted therapy , 2019, Nature Reviews Drug Discovery.

[88]  L. Akkari,et al.  Understanding the Origin and Diversity of Macrophages to Tailor Their Targeting in Solid Cancers , 2019, Front. Immunol..

[89]  B. Ren,et al.  Metabolic regulation of gene expression by histone lactylation , 2019, Nature.

[90]  R. Bernards,et al.  Inducing and exploiting vulnerabilities for the treatment of liver cancer , 2019, Nature.

[91]  Daniel G. Anderson,et al.  mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[92]  A. Boissonnas,et al.  Ontogeny of Tumor-Associated Macrophages , 2019, Front. Immunol..

[93]  Huiyin Lan,et al.  Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications , 2019, Journal of Hematology & Oncology.

[94]  Michael C. Schmid,et al.  Macrophage-Mediated Subversion of Anti-Tumour Immunity , 2019, Cells.

[95]  F. Greten,et al.  Inflammation and Cancer: Triggers, Mechanisms, and Consequences. , 2019, Immunity.

[96]  I. Amit,et al.  Lipid-Associated Macrophages Control Metabolic Homeostasis in a Trem2-Dependent Manner , 2019, Cell.

[97]  K. Mrozik,et al.  Clodronate-Liposome Mediated Macrophage Depletion Abrogates Multiple Myeloma Tumor Establishment In Vivo , 2019, Neoplasia.

[98]  M. Turner,et al.  Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression. , 2019, Cell metabolism.

[99]  E. Choi,et al.  Preventing the Solid Cancer Progression via Release of Anticancer-Cytokines in Co-Culture with Cold Plasma-Stimulated Macrophages , 2019, Cancers.

[100]  L. Cerchia,et al.  Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma , 2019, International journal of molecular sciences.

[101]  J. Joyce,et al.  Re-education of macrophages as a therapeutic strategy in cancer. , 2019, Immunotherapy.

[102]  T. Chtanova,et al.  Lymphatic Migration of Immune Cells , 2019, Front. Immunol..

[103]  R. Reis,et al.  Light‐triggered release of photocaged therapeutics ‐ Where are we now? , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[104]  Jeffrey S. Damrauer,et al.  CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors , 2019, bioRxiv.

[105]  R. König,et al.  Cognate Interaction With CD4+ T Cells Instructs Tumor-Associated Macrophages to Acquire M1-Like Phenotype , 2019, Front. Immunol..

[106]  C. Ries,et al.  Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response , 2019, Nature Cell Biology.

[107]  Brian Ruffell,et al.  Macrophages as regulators of tumour immunity and immunotherapy , 2019, Nature Reviews Immunology.

[108]  I. Ben-Sahra,et al.  Efferocytosis Fuels Requirements of Fatty Acid Oxidation and the Electron Transport Chain to Polarize Macrophages for Tissue Repair. , 2019, Cell metabolism.

[109]  Sui Huang,et al.  Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor , 2019, Proceedings of the National Academy of Sciences.

[110]  Yu Fu,et al.  Zoledronic acid promotes TLR‐4‐mediated M1 macrophage polarization in bisphosphonate‐related osteonecrosis of the jaw , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[111]  M. Overholtzer,et al.  Macropinocytosis and autophagy crosstalk in nutrient scavenging , 2018, Philosophical Transactions of the Royal Society B.

[112]  E. Müller,et al.  Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation , 2018, Front. Immunol..

[113]  I. Weissman,et al.  CD47 Blockade by Hu5F9‐G4 and Rituximab in Non‐Hodgkin's Lymphoma , 2018, The New England journal of medicine.

[114]  Emily K. Lehrman,et al.  CD47 Protects Synapses from Excess Microglia-Mediated Pruning during Development , 2018, Neuron.

[115]  F. Su,et al.  Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages , 2018, Cell.

[116]  Lixin Wei,et al.  Tumor necrosis factor-α promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells. , 2018, Cancer letters.

[117]  Jong Seong Roh,et al.  Damage-Associated Molecular Patterns in Inflammatory Diseases , 2018, Immune network.

[118]  Y. Mo,et al.  Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis. , 2018, Cancer research.

[119]  J. Gong,et al.  Iron overloaded polarizes macrophage to proinflammation phenotype through ROS/acetyl‐p53 pathway , 2018, Cancer medicine.

[120]  Michel Sadelain,et al.  Chimeric Antigen Receptor Therapy. , 2018, The New England journal of medicine.

[121]  K. Ballman,et al.  Somatic mutations precede acute myeloid leukemia years before diagnosis , 2018, Nature Medicine.

[122]  Qi Zhang,et al.  Hypoxia‐inducible factor‐1α/interleukin‐1β signaling enhances hepatoma epithelial–mesenchymal transition through macrophages in a hypoxic‐inflammatory microenvironment , 2018, Hepatology.

[123]  N. Bercovici,et al.  Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment , 2018, Proceedings of the National Academy of Sciences.

[124]  A. Gavin,et al.  The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015 , 2018, British Journal of Cancer.

[125]  S. Sleijfer,et al.  Overall survival in a trial of orally administered CCR2 inhibitor CCX872 in locally advanced/metastatic pancreatic cancer: Correlation with blood monocyte counts. , 2018 .

[126]  M. Heikenwalder,et al.  The immunology of hepatocellular carcinoma , 2018, Nature Immunology.

[127]  D. Radisky,et al.  Macrophagic “Crown-like Structures” Are Associated with an Increased Risk of Breast Cancer in Benign Breast Disease , 2017, Cancer Prevention Research.

[128]  R. Collins,et al.  Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial , 2017, The Lancet.

[129]  W. Wen,et al.  A positive-feedback loop between tumour infiltrating activated Treg cells and type 2-skewed macrophages is essential for progression of laryngeal squamous cell carcinoma , 2017, British Journal of Cancer.

[130]  Stefan Offermanns,et al.  Intravascular Survival and Extravasation of Tumor Cells. , 2017, Cancer cell.

[131]  Q. Luo,et al.  Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages. , 2017, ACS nano.

[132]  Jingqin Luo,et al.  Tissue‐Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression , 2017, Immunity.

[133]  B. Taylor,et al.  Treatment-Induced Mutagenesis and Selective Pressures Sculpt Cancer Evolution. , 2017, Cold Spring Harbor perspectives in medicine.

[134]  C. Swanton,et al.  Tumor Evolution as a Therapeutic Target. , 2017, Cancer discovery.

[135]  T. Petrova,et al.  Microenvironmental regulation of tumour angiogenesis , 2017, Nature Reviews Cancer.

[136]  M. Ferrari,et al.  Targeting Autocrine CCL5-CCR5 Axis Reprograms Immunosuppressive Myeloid Cells and Reinvigorates Antitumor Immunity. , 2017, Cancer research.

[137]  Daniel M. Corey,et al.  PD-1 expression by tumor-associated macrophages inhibits phagocytosis and tumor immunity , 2017, Nature.

[138]  B. Dwarakanath,et al.  Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy , 2017, Front. Oncol..

[139]  Zhaojian Liu,et al.  Overexpression of CD47 predicts poor prognosis and promotes cancer cell invasion in high-grade serous ovarian carcinoma. , 2017, American journal of translational research.

[140]  Yao-Xin Lin,et al.  Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment. , 2017, Biomaterials.

[141]  J. Gartner,et al.  T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer. , 2016, The New England journal of medicine.

[142]  Xipeng Wang,et al.  Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer. , 2016, Oncology reports.

[143]  Attila Horvath,et al.  Macrophage PPARγ, a Lipid Activated Transcription Factor Controls the Growth Factor GDF3 and Skeletal Muscle Regeneration. , 2016, Immunity.

[144]  J. Lovell,et al.  Mechanisms of light‐induced liposome permeabilization , 2016, Bioengineering & translational medicine.

[145]  Zhijie Kang,et al.  CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer , 2016, Scientific Reports.

[146]  J. Brown,et al.  Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization. , 2016, Neuro-oncology.

[147]  Eric C. Holland,et al.  The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas , 2016, Science.

[148]  F. Ginhoux,et al.  Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition. , 2016, Immunity.

[149]  Cassandra Willyard,et al.  Cancer therapy: an evolved approach , 2016, Nature.

[150]  M. Koch,et al.  Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients. , 2016, Cancer cell.

[151]  P. Steeg,et al.  Targeting metastasis , 2016, Nature Reviews Cancer.

[152]  R. Schwabe,et al.  Damage-associated molecular patterns in cancer: A double-edged sword , 2016, Oncogene.

[153]  K. Movahedi,et al.  Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment. , 2016, Biochimica et biophysica acta.

[154]  J. Joyce,et al.  Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response , 2015, Nature Reviews Cancer.

[155]  R. Schreiber,et al.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression , 2015, Cell.

[156]  Yarong Wang,et al.  Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA. , 2015, Cancer discovery.

[157]  I. Keklikoglou,et al.  Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy. , 2015, Cancer research.

[158]  C. Ries,et al.  CSF-1/CSF-1R targeting agents in clinical development for cancer therapy. , 2015, Current opinion in pharmacology.

[159]  Michael A. Hollingsworth,et al.  Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver , 2015, Nature Cell Biology.

[160]  Joshua M. Korn,et al.  Studying clonal dynamics in response to cancer therapy using high-complexity barcoding , 2015, Nature Medicine.

[161]  R. Cook,et al.  Efferocytosis creates a tumor microenvironment supportive of tumor survival and metastasis. , 2015, Cancer cell & microenvironment.

[162]  N. Ohkohchi,et al.  Kupffer cells decrease metastasis of colon cancer cells to the liver in the early stage. , 2014, International journal of oncology.

[163]  Sebastian Amigorena,et al.  Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity. , 2014, Cancer cell.

[164]  Vivien W. Chan,et al.  Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells. , 2014, Cancer cell.

[165]  K. Mertz,et al.  Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis , 2014, Nature.

[166]  P. De Baetselier,et al.  Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression , 2014, Front. Immunol..

[167]  Ruoning Wang,et al.  The Intercellular Metabolic Interplay between Tumor and Immune Cells , 2014, Front. Immunol..

[168]  Will Liao,et al.  The cellular and molecular origin of tumor-associated macrophages , 2014, Science.

[169]  E. Giannoni,et al.  Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression , 2014, Oncogene.

[170]  A. Orekhov,et al.  Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis , 2014, Front. Physiol..

[171]  T. K. van den Berg,et al.  Of macrophages and red blood cells; a complex love story , 2013, Front. Physiol..

[172]  Se Hoon Kim,et al.  Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. , 2013, Cancer cell.

[173]  Hideo Nakamura,et al.  Importance of direct macrophage ‐ Tumor cell interaction on progression of human glioma , 2012, Cancer science.

[174]  Wei Li.  Eat‐me signals: Keys to molecular phagocyte biology and “Appetite” control , 2012, Journal of cellular physiology.

[175]  Mikala Egeblad,et al.  Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells. , 2012, Cancer cell.

[176]  Hirohito Yamaguchi,et al.  Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1. , 2012, Cancer research.

[177]  J. Neefjes,et al.  Towards a systems understanding of MHC class I and MHC class II antigen presentation , 2011, Nature Reviews Immunology.

[178]  E. Brogi,et al.  Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer. , 2011, Genes & development.

[179]  J. Massagué,et al.  Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. , 2011, Cancer cell.

[180]  I. Holen,et al.  Tumour macrophages as potential targets of bisphosphonates , 2011, Journal of Translational Medicine.

[181]  C. Maley,et al.  Dispersal Evolution in Neoplasms: The Role of Disregulated Metabolism in the Evolution of Cell Motility , 2011, Cancer Prevention Research.

[182]  M. Giustetto,et al.  Synaptic Pruning by Microglia Is Necessary for Normal Brain Development , 2011, Science.

[183]  Jinghang Zhang,et al.  CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.

[184]  Karin Jirström,et al.  Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. , 2011, Cancer discovery.

[185]  Bing Li,et al.  The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair. , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[186]  Mikala Egeblad,et al.  Dynamic interplay between the collagen scaffold and tumor evolution. , 2010, Current opinion in cell biology.

[187]  P. Savagner.  The epithelial-mesenchymal transition (EMT) phenomenon. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[188]  D. Prince,et al.  Enhanced synaptic connectivity and epilepsy in C1q knockout mice , 2010, Proceedings of the National Academy of Sciences.

[189]  Z. Werb,et al.  Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.

[190]  Jeffrey W. Pollard,et al.  Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.

[191]  J. -. Park,et al.  TNF-α-induced ROS production triggering apoptosis is directly linked to Romo1 and Bcl-XL , 2010, Cell Death and Differentiation.

[192]  Jun Hee Lee,et al.  Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression , 2010, Cell.

[193]  A. Shiau,et al.  Toll-like Receptor 4 Signaling Promotes Tumor Growth , 2010, Journal of immunotherapy.

[194]  Michael R. Elliott,et al.  Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance , 2009, Nature.

[195]  C. Dinarello,et al.  Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.

[196]  Izhak Haviv,et al.  Co-evolution of tumor cells and their microenvironment. , 2009, Trends in genetics : TIG.

[197]  Hiroyuki Aburatani,et al.  The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase , 2008, Nature Cell Biology.

[198]  L. V. Van Eldik,et al.  MFG-E8 Regulates Microglial Phagocytosis of Apoptotic Neurons , 2008, Journal of Neuroimmune Pharmacology.

[199]  John D. Lambris,et al.  The Classical Complement Cascade Mediates CNS Synapse Elimination , 2007, Cell.

[200]  Alissa M. Weaver,et al.  Tumor Morphology and Phenotypic Evolution Driven by Selective Pressure from the Microenvironment , 2006, Cell.

[201]  Hiroyuki Aburatani,et al.  Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis , 2006, Nature Cell Biology.

[202]  John Condeelis,et al.  Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis , 2006, Cell.

[203]  J. Pollard,et al.  Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.

[204]  H. Neumann,et al.  Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2 , 2005, The Journal of experimental medicine.

[205]  A. Iwasaki,et al.  Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.

[206]  H. Mooney,et al.  The evolutionary impact of invasive species , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[207]  Xiaodong Feng,et al.  Angiogenesis in wound healing. , 2000, The journal of investigative dermatology. Symposium proceedings.

[208]  M. Kuwano,et al.  Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. , 2000, International journal of cancer.